Diabetic Macular Edema Treated With Ozurdex (DMEO)

Trial Profile

Diabetic Macular Edema Treated With Ozurdex (DMEO)

Phase of Trial: Phase II

Latest Information Update: 03 Aug 2016

At a glance

  • Drugs Dexamethasone (Primary)
  • Indications Diabetic macular oedema
  • Focus Pharmacodynamics
  • Acronyms DMEO
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 20 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 15 Dec 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Feb 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top